SN-001

• Description :

  SN-001 is a STING inhibitor with an IC50 of 3.82 μM[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  STING

• Type :

  Reference compound

• Related Pathways :

  Immunology/Inflammation

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/sn-001.html

• Purity :

  98.94

• Solubility :

  DMSO : 250 mg/mL (ultrasonic)

• Smiles :

  O=C(C1=CC=C(C2=CC=CC=C2)C=C1)NC3=CC=C(OC)C(NS(=O)(C4=CC=C(F)C=C4)=O)=C3

• Molecular Formula :

  C26H21FN2O4S

• Molecular Weight :

  476.52

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Hong Z, et al. STING inhibitors target the cyclic dinucleotide binding pocket. Proc Natl Acad Sci U S A. 2021 Jun 15;118 (24) :e2105465118.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [727699-84-5]